Team

Rodolfo Daniel Ávila-Avilés 

Daniel earned his undergraduate degree in Biotechnology from the Autonomous University of the State of Mexico (UAEMex) and Philosophy from the Vasco de Quiroga University (UVAQ). He completed a Masters in Genetics and Molecular Biology at the Center for Research and Advanced Studies of the National Polytechnic Institute (Cinvestav-IPN). He is a PhD student in Genetics and Molecular Biology at Cinvestav-IPN and a PhD in Materials Science at UAEMex.  In 2023, Daniel established and independent research group for Transdisciplinary Research for Drug Discovery. 

Ana Victoria Arredondo-Robles 

Master´s Student 

Victoria is from Toluca, México. She earned her undergraduate degree in Biotechnology from the Autonomous University of the State of Mexico. As a Master’s student, Victoria is currently working on the identification and characterization of novel new small molecules with the potential to enhance muscle differentiation and regeneration, such as inhibitors of the protein RANKL, and inhibitors of the mitochondrial adaptor protein MiD51 to regulate Drp1.

Manuel Gutiérrez-Rodríguez 

Undergraduate Student 

I'm Manuel Gutiérrez Rodríguez, undergrad student. Once I wanted to be a sportsman, now I use the computer to run molecular dynamics simulations to discover some new molecules that can be used as drugs in the future. Nowadays I'm working on a molecule that has potential to be employed to treat diabetes. This is the kind of racings I like, the ones that can save lives.

Erick Bahena-Culhuac 

Undergraduate Student 

Erick is a fourth-year Biotechnology student from the Autonomous University of the State of Mexico. In February 2022, he joined our group as an intership. Ever since, he has been working on the discovery and evaluation of potential new drugs. Currently, he is developing 2 projects. 1) The in silico search and in vitro evaluation of an inhibitor of WDR5-MLL1 interaction. A complex that plays a crucial role in diseases such as sarcopenia and AML. 2) Search and evaluation of an analog to Selinixor, as an alternative treatment for tumor suppression.